5 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
at Sutro. She will lead cross-functional activities to guide company-wide strategic alignment and value creation across Sutro's R&D pipeline, product
8-K
EX-99.2
STRO
Sutro Biopharma Inc
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
discovery as at commercial scale DAR NON-CONFIDENTIAL 5
Deep Arsenal of Tools in the R&D Pipeline Available to Attack Cancer (1) Novel and precise design
8-K
EX-99.1
STRO
Sutro Biopharma Inc
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
Leader of the Oncology R&D Group at Pfizer.
Stanley R. Frankel, M.D., joined the Sutro Scientific Advisory Board in June 2021. Dr. Frankel is currently
8-K
EX-99.2
STRO
Sutro Biopharma Inc
19 May 21
Regulation FD Disclosure
5:00pm
: Data as of October 30, 2020 from ASH 2020 21
Deep Arsenal of Tools in the R&D Pipeline Available to Attack Cancer (1) Novel and precise design to drive
- Prev
- 1
- Next